Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sirote Luengsupabul
Optimal INR Level in Patients With Atrial Fibrillation With EHRA Type 2 Valvular Heart Disease Receiving Warfarin
Journal of Arrhythmia
Cardiovascular Medicine
Cardiology
Related publications
Under-Use of Warfarin for Patients With Non-Valvular Atrial Fibrillation in Japan
Internal Medicine
Internal Medicine
Medicine
INR and Warfarin Plasma Level of Atrial Fibrillation Patients at Tertiary Hospital in West Sumatera
Advanced Science Letters
Environmental Science
Energy
Engineering
Health
Computer Science
Mathematics
Education
Type 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients With Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective Study
TH Open
Comparative Pharmacoeconomic Analysis of Rivaroxaban and Warfarin Usage in Patients With Non-Valvular Atrial Fibrillation
Jounal of arrhythmology
Effect and Risk of Novel Oral Anticoagulants Versus Warfarin in Patients With Non-Valvular Atrial Fibrillation
Journal of Cardiology
Cardiovascular Medicine
Cardiology
Optimal Intensity of International Normalized Ratio in Warfarin Therapy for Secondary Prevention of Stroke in Patients With Non-Valvular Atrial Fibrillation.
Internal Medicine
Internal Medicine
Medicine
Suboptimal Anticoagulant Management in Japanese Patients With Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention
Journal of Stroke and Cerebrovascular Diseases
Surgery
Neurology
Cardiovascular Medicine
Rehabilitation
Cardiology
PCV79 Compliance With Warfarin Therapy by Australian Patients With Atrial Fibrillation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Comparison of Non-Vitamin K Antagonist Oral Anticoagulants Versus Well-Managed Warfarin With a Lower INR Target of 1.5 to 2.5 in Asians Patients With Non-Valvular Atrial Fibrillation
PLoS ONE
Multidisciplinary
